<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1279</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12445737</PubmedId>
            <Abstract>MHC tetramers have proven to be powerful reagents for the analysis of MHC class I-restricted T cells. However, generating similarly reliable reagents for MHC class II-restricted T cells has been elusive. Here we evaluated the utility of MHC class II:gamma2aFc multimers, which contain the MHC class II extracellular domains, with or without recombinantly attached peptides, dimerized via a fos-jun leucine zipper and attached to the hinge of murine IgG2a. We have successfully generated 24 multimers in either myeloma or Drosophila melanogaster S2 cells, with an average yield of 7 mg/L. 'Empty' MHC class II:gamma2aFc multimers were effectively used in peptide binding assays. Similar versions that contained recombinantly attached peptides stimulated T cells in an antigen-specific, MHC-restricted manner, and identified antigen-specific nai;ve and effector T cells by flow cytometry. Furthermore, we have successfully used these reagents to stain T cells generated following viral infection. Thus, MHC class II:gamma2aFc multimers are robust and reliable reagents for the analysis of MHC class II-restricted T cells.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>137-51</ArticlePages>
            <ArticleTitle>Reliable generation and use of MHC class II:gamma2aFc multimers for the identification of antigen-specific CD4(+) T cells.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Arnold</LastName>
                    <ForeName>Paula Y</ForeName>
                </Author>
                <Author>
                    <LastName>Vignali</LastName>
                    <ForeName>Kate M</ForeName>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Timothy B</ForeName>
                </Author>
                <Author>
                    <LastName>La Gruta</LastName>
                    <ForeName>Nicole L</ForeName>
                </Author>
                <Author>
                    <LastName>Cauley</LastName>
                    <ForeName>Linda S</ForeName>
                </Author>
                <Author>
                    <LastName>Haynes</LastName>
                    <ForeName>Laura</ForeName>
                </Author>
                <Author>
                    <LastName>Scott Adams</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Swain</LastName>
                    <ForeName>Susan L</ForeName>
                </Author>
                <Author>
                    <LastName>Woodland</LastName>
                    <ForeName>David L</ForeName>
                </Author>
                <Author>
                    <LastName>Vignali</LastName>
                    <ForeName>Dario A A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Immunology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;Histocompatibility Antigens Class II;Immunoglobulin Fragments;Recombinant Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Base Sequence; CD4-Positive T-Lymphocytes(immunology); Drosophila melanogaster; Epitopes, T-Lymphocyte(immunology); Female; Flow Cytometry; Histocompatibility Antigens Class II(immunology); Immunoglobulin Fragments(immunology); Influenza A virus(immunology); Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Sequence Data; Plasmids(immunology); Recombinant Proteins(immunology); Sendai virus(immunology); Specific Pathogen-Free Organisms; Tumor Cells, Cultured</ArticleMeshHeadingsList>
            <Journal>
                <Volume>271</Volume>
                <Issue>1-2</Issue>
                <Title>Journal of immunological methods</Title>
                <Issn>0022-1759</Issn>
                <MedlineTa>J Immunol Methods</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HEL 48-63</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DGSTDYGILQINSRWW</LinearSequence>
                        <StartingPosition>48</StartingPosition>
                        <EndingPosition>63</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>8497</EpitopeId>
                <ReferenceStartingPosition>48</ReferenceStartingPosition>
                <ReferenceEndingPosition>63</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>19418</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000230</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TDYGILQINS</LinearSequence>
                                            <StartingPosition>69</StartingPosition>
                                            <EndingPosition>78</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P00698.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9031</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HEL 52-60</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>3A9  thymoma cells origin is not detailed, but its TCR specificity is said to be to HEL 52-60 peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>3A9</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>110</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HEL 48-63</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DGSTDYGILQINSRWW</LinearSequence>
                                        <StartingPosition>48</StartingPosition>
                                        <EndingPosition>63</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1LKS_A</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9031</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ak:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stimulate IL-2 production from HEL 52-60 specific CD4+ T cell hybridoma but not from other hybridomas. This and other data support the use of this constructs for the stimulation of epitope specific cells.  MHC:γ2Fc-peptide molecules were coated on plates where hybridoma was seeded. CTLL-2 cells were grown in the presence of hybridoma supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>19354</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000040</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Naïve epitope-specific-TCR transgenic mice were the source of splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>3A9</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>110</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HEL 48-63</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DGSTDYGILQINSRWW</LinearSequence>
                                        <StartingPosition>48</StartingPosition>
                                        <EndingPosition>63</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1LKS_A</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9031</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ak:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stain 3A9 TCR (HEL 52-60 specific) transgenic CD4+ splenocytes, with a sensibility of up to 2% of cells effectively detected. Similar results are obtained with the dimeric form or when a tetrameric molecule is constructed by loading onto Protein A (which has a valency of 2 for Fc binding). This and other data support the use of this constructs for the identification of epitope specific cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 b</LocationOfData>
                        <MhcBindingId>19353</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Actually peptide 48-62 is used in this assay. MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay,  where epitope competes the binding of another, biotinilated, IAk binding peptide demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>110</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 22-35</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GYSLGNWVCAAKFE</LinearSequence>
                        <StartingPosition>22</StartingPosition>
                        <EndingPosition>35</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>23467</EpitopeId>
                <ReferenceStartingPosition>22</ReferenceStartingPosition>
                <ReferenceEndingPosition>35</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>19411</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SLGNWVCAA</LinearSequence>
                                            <StartingPosition>42</StartingPosition>
                                            <EndingPosition>50</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P00698.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9031</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HEL 24-32</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell hybridoma origin and generation is not detailed, but its specificity is said to be to HEL 24-32 peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>PA4-1H5</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>110</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HEL 22-35</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GYSLGNWVCAAKFE</LinearSequence>
                                        <StartingPosition>22</StartingPosition>
                                        <EndingPosition>35</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1LKS_A</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9031</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ak:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stimulate IL-2 production from HEL 24-32 specific CD4+ T cell hybridoma but not from other hybridomas. This and other data support the use of this constructs for the stimulation of epitope specific cells.  MHCγ2F-peptide molecules were coated on plates where hybridoma was seeded. CTLL-2 cells were grown in the presence of hybridoma supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 b</LocationOfData>
                        <MhcBindingId>19410</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Actually peptide 21-35 is used in this assay. MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated, IAk binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>110</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 116-129</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KGTDVQAWIRGCRL</LinearSequence>
                        <StartingPosition>116</StartingPosition>
                        <EndingPosition>129</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LSB_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>31068</EpitopeId>
                <ReferenceStartingPosition>116</ReferenceStartingPosition>
                <ReferenceEndingPosition>129</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>19434</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DVQAWIRGC</LinearSequence>
                                            <StartingPosition>137</StartingPosition>
                                            <EndingPosition>145</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P00698.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9031</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HEL 119-127</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell hybridoma origin and generation is not detailed, but its specificity is said to be to HEL 119-127 peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>PA1C9</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>110</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HEL 116-129</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGTDVQAWIRGCRL</LinearSequence>
                                        <StartingPosition>116</StartingPosition>
                                        <EndingPosition>129</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1LSB_A</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9031</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Actually peptide 117-129  is used in this assay. H-2Ak:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stimulate IL-2 production from HEL 119-127 specific CD4+ T cell hybridoma but not from other hybridomas. This and other data support the use of this constructs for the stimulation of epitope specific cells.  MHC:γ2Fc-peptide molecules were coated on plates where hybridoma was seeded. CTLL-2 cells were grown in the presence of hybridoma supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 b</LocationOfData>
                        <MhcBindingId>19433</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated, IAk binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>110</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 71-86</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GSRNLCNIPCSALLSS</LinearSequence>
                        <StartingPosition>71</StartingPosition>
                        <EndingPosition>86</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Swiss-prot entry</LocationOfData>
                <EpitopeId>22482</EpitopeId>
                <ReferenceStartingPosition>71</ReferenceStartingPosition>
                <ReferenceEndingPosition>86</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 b</LocationOfData>
                        <MhcBindingId>19435</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated, IAk binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>110</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 33-47</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KFESNFNTQATNRNT</LinearSequence>
                        <StartingPosition>33</StartingPosition>
                        <EndingPosition>47</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Swiss-prot entry</LocationOfData>
                <EpitopeId>30721</EpitopeId>
                <ReferenceStartingPosition>33</ReferenceStartingPosition>
                <ReferenceEndingPosition>47</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 b</LocationOfData>
                        <MhcBindingId>19437</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated, IAk binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>110</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 46-61</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NTDGSTDYGILQINSR</LinearSequence>
                        <StartingPosition>46</StartingPosition>
                        <EndingPosition>61</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Swiss-prot entry</LocationOfData>
                <EpitopeId>46072</EpitopeId>
                <ReferenceStartingPosition>46</ReferenceStartingPosition>
                <ReferenceEndingPosition>61</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 b</LocationOfData>
                        <MhcBindingId>19438</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where biontinilated epitope competes the binding of other IAk binding peptides, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>110</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 4-16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GRCELAAAMKRHG</LinearSequence>
                        <StartingPosition>4</StartingPosition>
                        <EndingPosition>16</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>21999</EpitopeId>
                <ReferenceStartingPosition>4</ReferenceStartingPosition>
                <ReferenceEndingPosition>16</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>19444</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CELAAAMKR</LinearSequence>
                                            <StartingPosition>24</StartingPosition>
                                            <EndingPosition>32</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P00698.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9031</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HEL 6-14</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell hybridoma origin and generation is not detailed, but its specificity is said to be to HEL 6-14 peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>PA4-4E6</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>118</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HEL 4-16</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GRCELAAAMKRHG</LinearSequence>
                                        <StartingPosition>4</StartingPosition>
                                        <EndingPosition>16</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1LKS_A</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9031</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ek:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stimulate IL-2 production from HEL 6-14 specific CD4+ T cell hybridoma but not from other hybridomas. This and other data support the use of this constructs for the stimulation of epitope specific cells.  MHC:γ2Fc-peptide molecules were coated on plates where hybridoma was seeded. CTLL-2 cells were grown in the presence of hybridoma supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 85-100</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SSDITASVNCAKKIVS</LinearSequence>
                        <StartingPosition>85</StartingPosition>
                        <EndingPosition>100</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Swiss-prot entry</LocationOfData>
                <EpitopeId>60949</EpitopeId>
                <ReferenceStartingPosition>85</ReferenceStartingPosition>
                <ReferenceEndingPosition>100</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 a</LocationOfData>
                        <MhcBindingId>19445</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila or myeloma cells. This assay, wherewhere epitope competes the binding of another, biotinilated, IEk binding peptides, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>118</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 105-119</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MNAWVAWRNRCKGTD</LinearSequence>
                        <StartingPosition>105</StartingPosition>
                        <EndingPosition>119</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Swiss-prot entry</LocationOfData>
                <EpitopeId>42191</EpitopeId>
                <ReferenceStartingPosition>105</ReferenceStartingPosition>
                <ReferenceEndingPosition>119</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 a</LocationOfData>
                        <MhcBindingId>19446</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila or myeloma cells. This assay, where epitope competes the binding of another, biotinilated, IEk binding peptides, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>118</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 81-97</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SALLSSDITASVNCAKK</LinearSequence>
                        <StartingPosition>81</StartingPosition>
                        <EndingPosition>97</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Swiss-prot entry</LocationOfData>
                <EpitopeId>56868</EpitopeId>
                <ReferenceStartingPosition>81</ReferenceStartingPosition>
                <ReferenceEndingPosition>97</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 a</LocationOfData>
                        <MhcBindingId>19448</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila or myeloma cells. This assay, where biotinilated epitope competes the binding of other IEk binding peptides, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>118</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HEL 1-18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KVFGRCELAAAMKRHGLD</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>18</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1LKS_A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9031</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>33998</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>18</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Entry in Swissprot  is named Lysozyme C precursor, 1,4-beta-N-acetylmuramidase C, Allergen Gal d 4 and Gal d IV, and it includes 18 aa signal peptide.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>19455</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CELAAAMKR</LinearSequence>
                                            <StartingPosition>24</StartingPosition>
                                            <EndingPosition>32</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P00698.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9031</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HEL 6-14</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell hybridoma origin and generation is not detailed, but its specificity is said to be to HEL 6-14 peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>PA4-4E6</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>118</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HEL 1-18</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KVFGRCELAAAMKRHGLD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>18</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1LKS_A</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9031</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ek:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stimulate IL-2 production from epitope specific CD4+ T cell hybridoma but not from other hybridomas. This and other data support the use of this constructs for the stimulation of epitope specific cells.  MHC:γ2Fc-peptide molecules were coated on plates where hybridoma was seeded. CTLL-2 cells were grown in the presence of hybridoma supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 a</LocationOfData>
                        <MhcBindingId>19454</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila or myeloma cells. This assay, where epitope competes the binding of another, biotinilated, IEk binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>118</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GAD 284-300</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLKKGAAALGIGTDSVI</LinearSequence>
                        <StartingPosition>284</StartingPosition>
                        <EndingPosition>300</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P48320.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>59217</EpitopeId>
                <ReferenceStartingPosition>284</ReferenceStartingPosition>
                <ReferenceEndingPosition>300</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>19461</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AAALGIGTD</LinearSequence>
                                            <StartingPosition>289</StartingPosition>
                                            <EndingPosition>297</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P48320.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>GAD 289-297</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell hybridoma origin and generation is not detailed, but its specificity is said to be to GAD 289-297 peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>PA17.9G7</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>109</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>GAD 284-300</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLKKGAAALGIGTDSVI</LinearSequence>
                                        <StartingPosition>284</StartingPosition>
                                        <EndingPosition>300</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P48320.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Actually peptide 284-299 is used in this assay. H-2Ag7:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stimulate IL-2 production from GAD 289-297-specific CD4+ T cell hybridoma but not from other hybridomas. This and other data support the use of this constructs for the stimulation of epitope specific cells.  MHC:γ2Fc-peptide molecules were coated on plates where hybridoma was seeded. CTLL-2 cells were grown in the presence of hybridoma supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 c</LocationOfData>
                        <MhcBindingId>19460</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2a Fc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated, IAg7 binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>109</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GAD 206-220</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TYEIAPVFVLLEYVT</LinearSequence>
                        <StartingPosition>206</StartingPosition>
                        <EndingPosition>220</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P48320.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>67328</EpitopeId>
                <ReferenceStartingPosition>206</ReferenceStartingPosition>
                <ReferenceEndingPosition>220</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>19499</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IAPVFVLLE</LinearSequence>
                                            <StartingPosition>209</StartingPosition>
                                            <EndingPosition>217</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P48320.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>GAD 209-217</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell hybridoma origin and generation is not detailed, but its specificity is said to be to GAD 209-217 peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>PA19.5E11</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>109</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>GAD 206-220</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TYEIAPVFVLLEYVT</LinearSequence>
                                        <StartingPosition>206</StartingPosition>
                                        <EndingPosition>220</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P48320.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Actually peptide 207-220 is used in this assay. H-2Ag7:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stimulate IL-2 production from GAD 209-217-specific CD4+ T cell hybridoma but not from other hybridomas. This and other data support the use of this constructs for the stimulation of epitope specific cells.  MHC:γ2Fc-peptide molecules were coated on plates where hybridoma was seeded. CTLL-2 cells were grown in the presence of hybridoma supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 c</LocationOfData>
                        <MhcBindingId>19498</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2aFc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated, IAg7 binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>109</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GAD 220-237</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TLKKMREIIGWPGGSGDG</LinearSequence>
                        <StartingPosition>220</StartingPosition>
                        <EndingPosition>237</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P48320.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>64877</EpitopeId>
                <ReferenceStartingPosition>220</ReferenceStartingPosition>
                <ReferenceEndingPosition>237</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 c</LocationOfData>
                        <MhcBindingId>19500</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2aFc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where free epitope competes the binding of the biotinilated version of it, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>109</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GAD 510-524</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PPSLRTLEDNEERMS</LinearSequence>
                        <StartingPosition>510</StartingPosition>
                        <EndingPosition>524</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P48320.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>48917</EpitopeId>
                <ReferenceStartingPosition>510</ReferenceStartingPosition>
                <ReferenceEndingPosition>524</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 c</LocationOfData>
                        <MhcBindingId>19502</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2aFc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated IAg7 binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>109</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GAD 524-538</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SRLSKVAPVIKARMM</LinearSequence>
                        <StartingPosition>524</StartingPosition>
                        <EndingPosition>538</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P48320.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>60728</EpitopeId>
                <ReferenceStartingPosition>510</ReferenceStartingPosition>
                <ReferenceEndingPosition>524</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2 c</LocationOfData>
                        <MhcBindingId>19504</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>MHC molecule is a MHC class II:γ2aFc dimer (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila cells. This assay, where epitope competes the binding of another, biotinilated IAg7 binding peptide, demonstrates the effective use of this construct for peptide binding assays.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>109</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PCC 88-104</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KAERADLIAYLKQATAK</LinearSequence>
                        <StartingPosition>89</StartingPosition>
                        <EndingPosition>105</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P00021.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>8932</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>29790</EpitopeId>
                <ReferenceStartingPosition>88</ReferenceStartingPosition>
                <ReferenceEndingPosition>104</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>19517</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000265</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Naïve AND TCR (Bα11/Vβ3) transgenic mice splenocytes were used for this assay.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>AND</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>118</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PCC 88-104</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAERADLIAYLKQATAK</LinearSequence>
                                        <StartingPosition>89</StartingPosition>
                                        <EndingPosition>105</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P00021.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>8932</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ek:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), purified from S2 Drosophila or myeloma cells and loaded in vitro with epitope are able to stimulate IL-2 production by epitope specific CD4+ cells. This and other data support the use of this constructs for the stimulation of epitope specific cells.  Splenocytes were incubated on plates previously coated with peptide loaded MHC molecules. CTLL-2 cells were grown in the presence of culture supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>MCC 96-108</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RADLIAYLKQATK</LinearSequence>
                        <StartingPosition>96</StartingPosition>
                        <EndingPosition>108</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P00039.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>7130</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>53082</EpitopeId>
                <ReferenceStartingPosition>96</ReferenceStartingPosition>
                <ReferenceEndingPosition>108</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4, 5</LocationOfData>
                        <TCellId>19519</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000265</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Naïve or in vitro activated AND TCR (Bα11/Vβ3) transgenic mice splenocytes were used for this assay.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>AND</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>118</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>MCC 96-108</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RADLIAYLKQATK</LinearSequence>
                                        <StartingPosition>96</StartingPosition>
                                        <EndingPosition>108</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P00039.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>7130</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ek:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stain epitope specific ANDT TCR transgenic CD4+ splenocytes, both of naïve and Th1 activated phenotypes, with a sensibility of up to 2% of cells effectively detected. Similar results are obtained with the dimeric form or when a tetrameric molecule is constructed by loading onto Protein A (which has a valency of 2 for Fc binding). This and other data support the use of this constructs for the identification of epitope specific cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>19518</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000265</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Naïve AND TCR (Bα11/Vβ3) transgenic mice splenocytes were used for this assay.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>AND</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>118</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>MCC 96-108</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RADLIAYLKQATK</LinearSequence>
                                        <StartingPosition>96</StartingPosition>
                                        <EndingPosition>108</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P00039.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>7130</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>H-2Ek:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper), with genetically linked epitope are able to stimulate IL-2 production by epitope specific CD4+ cells. This and other data support the use of this constructs for the stimulation of epitope specific cells.  Splenocytes were incubated on plates previously coated with peptide loaded MHC molecules. CTLL-2 cells were grown in the presence of culture supernatants and assayed for  3H-thymidine incorporation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HN 419-433</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DRVYIYTRSSGWHSQ</LinearSequence>
                        <StartingPosition>419</StartingPosition>
                        <EndingPosition>433</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04853.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11191</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>10066</EpitopeId>
                <ReferenceStartingPosition>419</ReferenceStartingPosition>
                <ReferenceEndingPosition>433</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Several, but not all, Sendai virus strains harbor this exact epitope sequence.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Fig 6</LocationOfData>
                        <TCellId>19520</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>6-12 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DOID:934</DiseaseState>
                                <DiseaseStage>Acute/Recent onset</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11191</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intranasal</Route>
                                <DoseSchedule>1 dose of  200 EID50</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Lung airways cells were collected 10 days post infection.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Bronchial Aveolar Lavage (BAL)</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>181</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HN 419-433</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DRVYIYTRSSGWHSQ</LinearSequence>
                                        <StartingPosition>419</StartingPosition>
                                        <EndingPosition>433</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04853.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11191</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>13.0</QuantitativeMeasurement>
                            <AssayComments>H-2Ab:γ2aFc molecules (where 2 MHC molecules are bound to a γ2a Fc domain by Jun-Fos leucine zipper) with genetically linked epitope are able to stain CD4+ lung lymphocytes from Sendai immunized mice but not from Flu infected animals, and the frequency contained is consistent with previous estimates based on intracellualr cytokine staining. This and other data support the use of this constructs for the identification of epitope specific cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

